```html

Yellowish Plaques on the Skin

What is Yellowish Plaques on Skin?

Yellowish plaques are raised, often solid‑looking lesions that appear on the surface of the skin with a yellow to golden hue. The term “plaque” refers to a lesion that is larger than 1 cm in diameter and typically has a flat‑top, whereas “yellowish” describes the colour caused by excess keratin, lipids, or pigment. These plaques can be painless or itchy, solitary or multiple, and may arise anywhere on the body, though some conditions favour specific regions (e.g., the scalp, elbows, or trunk).

Because several unrelated skin disorders produce yellow‑coloured plaques, identifying the exact cause requires a careful look at the lesion’s texture, distribution, associated symptoms, and the patient’s medical history.

Common Causes

Below are the most frequently encountered conditions that present with yellowish plaques. Most are benign, but a few can signal more serious systemic disease.

• Seborrheic keratosis – Benign, waxy plaques that often turn yellow‑brown with age.
• Xanthomas – Lipid‑rich deposits associated with high cholesterol or triglycerides; appear as yellow, firm plaques especially on elbows, knees, and tendons.
• Psoriasis (plaque type) – Thick, silvery‑white scales may have a yellowish base when the skin is inflamed.
• Lichen planus (hypertrophic type) – Thick, hyperkeratotic plaques that can appear yellowish due to over‑keratinisation.
• Discoid lupus erythematosus (DLE) – Chronic lesions that may become yellow‑brown with scarring.
• Variable dermatitis (e.g., chronic eczema) – Long‑standing inflammation can lead to lichenified, yellow‑tinged plaques.
• Cutaneous T‑cell lymphoma (mycosis fungoides) – Early patches/plaques may look yellow‑orange before turning erythro‑pink.
• Granuloma annulare (deep variant) – Firm, annular plaques with a yellow‑tan hue.
• Keratinocyte carcinoma in situ (Bowen’s disease) – Slowly growing, scaly plaque that can turn yellow‑white.
• Secondary syphilis – Can produce copper‑brown to yellowish plaques on the palms/soles and trunk.

Associated Symptoms

Yellowish plaques rarely appear in isolation. The presence of other signs can help narrow the diagnosis:

• Itching or burning sensation (common with eczema, psoriasis, and seborrheic keratosis).
• Scaling or flaking skin.
• Pain or tenderness (especially with xanthomas over tendons or infected lesions).
• Systemic features such as fatigue, fever, weight loss (suggestive of lupus, lymphoma, or infection).
• Joint pain or swelling (xanthomas may accompany gout or familial hypercholesterolemia).
• Changes in nail texture or colour (psoriasis, lupus).
• Recent medication use (drug‑induced lichenoid reactions).
• Family history of high cholesterol, autoimmune disease, or skin cancer.

When to See a Doctor

Most yellowish plaques are harmless, but you should schedule a medical appointment if you notice any of the following:

• Lesion growth in size, thickness, or number within weeks.
• Persistent itching, pain, or burning that does not improve with over‑the‑counter creams.
• Signs of infection – redness spreading beyond the plaque, warmth, pus, or fever.
• Bleeding, ulceration, or crusting of the plaque.
• Patchy loss of colour or the development of a “strawberry” appearance (possible melanoma).
• Associated systemic symptoms such as unexplained weight loss, night sweats, or joint swelling.
• Known history of high cholesterol, autoimmune disease, or skin cancer.

Diagnosis

Doctor evaluation typically follows a stepwise approach:

1. Clinical Examination

• Visual inspection of colour, size, shape, and distribution.
• Palpation to assess firmness, tenderness, and depth.
• Dermoscopic evaluation (hand‑held magnifier) to look for specific patterns that differentiate benign from malignant lesions.

2. Medical History

• Onset and progression of lesions.
• Family history of lipid disorders, psoriasis, or skin cancer.
• Medication list (some drugs cause lichenoid reactions).
• Systemic symptoms (fevers, joint pain, etc.).

3. Laboratory Tests (when indicated)

• Lipid panel – to detect hyperlipidaemia in suspected xanthomas.
• Autoimmune work‑up (ANA, anti‑dsDNA) for lupus.
• CBC, ESR/CRP – markers of inflammation.

4. Skin Biopsy

If the diagnosis remains uncertain, a punch or excisional biopsy is performed. Histopathology can differentiate between:

• Benign hyperkeratotic lesions (seborrheic keratosis, lichen planus).
• Inflammatory dermatoses (psoriasis, eczema).
• Neoplastic processes (Bowen’s disease, cutaneous T‑cell lymphoma).

5. Imaging (rare)

In cases of deep xanthomas or suspected internal disease, ultrasound or MRI may be ordered to evaluate underlying tissues.

Treatment Options

Treatment hinges on the underlying cause. Below are general and condition‑specific recommendations.

General Skin Care

• Gentle cleansing with fragrance‑free soaps.
• Moisturize twice daily using ceramide‑rich emollients.
• Avoid picking or scratching lesions to prevent secondary infection.

Topical Therapies

• Corticosteroid creams (e.g., clobetasol 0.05%) – Reduces inflammation in eczema, psoriasis, or lichenoid reactions.
• Calcipotriene or tazarotene – Vitamin D analogues for plaque psoriasis.
• Retinoids (tretinoin 0.025–0.05%) – Effective for seborrheic keratosis and early actinic keratoses.
• Statin‑containing creams – Investigational for localized xanthomas (still under study).

Systemic Medications

• Oral retinoids (acitretin) – For extensive psoriasis or keratinization disorders.
• Systemic steroids – Short courses for severe inflammatory flares (e.g., lupus).
• Biologic agents (adalimumab, secukinumab) – For moderate‑to‑severe plaque psoriasis unresponsive to topical therapy.
• Lipid‑lowering therapy (statins, fibrates) – First‑line for xanthomas secondary to hyperlipidaemia.
• Immunomodulators (hydroxychloroquine) – Often used in cutaneous lupus.

Procedural Options

• Cryotherapy – Liquid nitrogen freezing, effective for isolated seborrheic keratoses.
• Laser therapy (CO₂ or erbium‑YAG) – Removes thick plaques, especially in psoriasis or keratoacanthoma‑like lesions.
• Electrocautery or shave excision – For solitary, suspicious plaques requiring histologic confirmation.
• Phototherapy (narrow‑band UVB) – Beneficial for widespread plaque psoriasis.

Home Remedies (Adjunctive)

• Apply cool oatmeal compresses to soothe itching.
• Use over‑the‑counter antihistamine (cetirizine 10 mg) if itching interferes with sleep.
• For mild xanthomas, a diet low in saturated fats and high in omega‑3 fatty acids may modestly improve lesions over months.

Prevention Tips

• Maintain healthy lipid levels – Regular lipid screening, a balanced diet, and exercise reduce risk of xanthomas.
• Protect skin from chronic irritation – Use barrier creams for hands, avoid harsh chemicals.
• Sun protection – Broad‑spectrum sunscreen (SPF 30+) lowers risk of actinic changes that can mimic yellow plaques.
• Manage underlying autoimmune conditions – Adherence to prescribed meds (e.g., hydroxychloroquine for lupus) prevents flare‑related plaques.
• Avoid tobacco and excess alcohol – Both can exacerbate psoriasis and impair healing.
• Regular skin checks – Self‑examination every month; schedule dermatology visits for suspicious or changing lesions.

Emergency Warning Signs

Key Take‑aways

Yellowish plaques are a visual clue that a range of dermatologic or systemic conditions may be present. While many are benign and respond to simple skin‑care measures, some signal serious disease that requires prompt evaluation. Recognising accompanying symptoms, seeking professional assessment when lesions change or cause distress, and following preventive lifestyle measures can greatly improve outcomes.

References:

• Mayo Clinic. “Seborrheic keratosis.” Mayoclinic.org.
• American Heart Association. “What are xanthomas?” heart.org.
• Cleveland Clinic. “Psoriasis Overview.” my.clevelandclinic.org.
• National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Lichen Planus.” niams.nih.gov.
• CDC. “Secondary Syphilis.” cdc.gov.
• National Psoriasis Foundation. “Biologic Therapies.” psoriasis.org.
• World Health Organization. “Skin NTDs – a public health challenge.” who.int.

```